Page last updated: 2024-11-04

argininamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

argininamide: RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-arginine amide : An amino acid amide resulting from the formal condensation of the carboxy group of L-arginine with ammonia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID447555
CHEBI ID21236
SCHEMBL ID304115
MeSH IDM0189278

Synonyms (23)

Synonym
argininamide
(2s)-2-amino-5-(diaminomethylideneamino)pentanamide
arg-nh2
2-(s)-amino-5-guanidinopentanoic acid amide
l-arm
l-argininamide
l-2-amino-5-guanidinovaleramide
l-arginine amide
CHEBI:21236
2788-83-2
(2s)-2-amino-5-guanidino-pentanamide
l-arginamide
unii-29626ze0wy
29626ze0wy ,
arginine amide
pentanamide, 2-amino-5-((aminoiminomethyl)amino)-, (2s)-
argininamide, l-
SCHEMBL304115
h-arg-nh2
ULEBESPCVWBNIF-BYPYZUCNSA-N
AKOS025147190
Q27109380
(s)-2-amino-5-guanidinopentanamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
amino acid amideAn amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group.
guanidinesAny organonitrogen compound containing a carbamimidamido (guanidino) group. Guanidines have the general structure (R(1)R(2)N)(R(3)R(4)N)C=N-R(5) and are related structurally to amidines and ureas.
L-arginine derivativeA proteinogenic amino acid derivative resulting from reaction of L-arginine at the amino group, the carboxy group, or the guanidyl group, or from the replacement of any hydrogen of L-arginine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (3.85)18.7374
1990's6 (11.54)18.2507
2000's25 (48.08)29.6817
2010's19 (36.54)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (98.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]